AJP - Lung Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 287: L1042-L1047, 2004. First published July 16, 2004; doi:10.1152/ajplung.00155.2004
1040-0605/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/5/L1042    most recent
00155.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamada, M.
Right arrow Articles by Sasaki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamada, M.
Right arrow Articles by Sasaki, H.

Interferon-{gamma}: a key contributor to hyperoxia-induced lung injury in mice

Mitsuhiro Yamada, Hiroshi Kubo, Seiichi Kobayashi, Kota Ishizawa, and Hidetada Sasaki

Department of Geriatric and Respiratory Medicine, Tohoku University School of Medicine, Sendai, Miyagi, Japan 980-8574

Submitted 30 April 2004 ; accepted in final form 15 July 2004

Hyperoxia-induced lung injury complicates the care of many critically ill patients who receive supplemental oxygen therapy. Hyperoxic injury to lung tissues is mediated by reactive oxygen species, inflammatory cell activation, and release of cytotoxic cytokines. IFN-{gamma} is known to be induced in lungs exposed to high concentrations of oxygen; however, its contribution to hyperoxia-induced lung injury remains unclear. To determine whether IFN-{gamma} contributes to hyperoxia-induced lung injury, we first used anti-mouse IFN-{gamma} antibody to blockade IFN-{gamma} activity. Administration of anti-mouse IFN-{gamma} antibody inhibited hyperoxia-induced increases in pulmonary alveolar permeability and neutrophil migration into lung air spaces. To confirm that IFN-{gamma} contributes to hyperoxic lung injury, we then simultaneously exposed IFN-{gamma}-deficient (IFN-{gamma}–/–) mice and wild-type mice to hyperoxia. In the early phase of hyperoxia, permeability changes and neutrophil migration were significantly reduced in IFN-{gamma}–/– mice compared with wild-type mice, although the differences in permeability changes and neutrophil migration between IFN-{gamma}–/– mice and wild-type mice were not significant in the late phase of hyperoxia. The concentrations of IL-12 and IL-18, two cytokines that play a role in IFN-{gamma} induction, significantly increased in bronchoalveolar lavage fluid after exposure to hyperoxia in both IFN-{gamma}–/– mice and wild-type mice, suggesting that hyperoxia initiates upstream events that result in IFN-{gamma} production. Although there was no significant difference in overall survival, IFN-{gamma}–/– mice had a better early survival rate than did the wild-type mice. Therefore, these data strongly suggest that IFN-{gamma} is a key molecular contributor to hyperoxia-induced lung injury.

neutrophils; inflammation; oxygen toxicity; cytokines; acute lung injury



Address for reprint requests and other correspondence: H. Kubo, Dept. of Geriatric and Respiratory Medicine, Tohoku Univ. School of Medicine, 1-1 Seiryoumachi, Aobaku, Sendai 980-8574, Japan (E-mail: hkubo{at}geriat.med.tohoku.ac.jp)




This article has been cited by other articles:


Home page
PediatricsHome page
N. Ambalavanan, W. A. Carlo, C. T. D'Angio, S. A. McDonald, A. Das, D. Schendel, P. Thorsen, R. D. Higgins, and for the Eunice Kennedy Shriver National Institute
Cytokines Associated With Bronchopulmonary Dysplasia or Death in Extremely Low Birth Weight Infants
Pediatrics, April 1, 2009; 123(4): 1132 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. Teske, A. A. Bohn, J. P. Hogaboam, and B. P. Lawrence
Aryl Hydrocarbon Receptor Targets Pathways Extrinsic to Bone Marrow Cells to Enhance Neutrophil Recruitment during Influenza Virus Infection
Toxicol. Sci., March 1, 2008; 102(1): 89 - 99.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. He, H. Kubo, K. Ishizawa, A. E. Hegab, Y. Yamamoto, H. Yamamoto, and M. Yamaya
The role of the receptor for advanced glycation end-products in lung fibrosis
Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1427 - L1436.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.